Literature DB >> 1688755

Structural and functional analysis of C3 using monoclonal antibodies.

J Alsenz1, J D Becherer, B Nilsson, J D Lambris.   

Abstract

Mesh：

Substances：

Year:  1990        PMID： 1688755     DOI： 10.1007/978-3-642-74977-3_13

Source DB:  PubMed          Journal:  Curr Top Microbiol Immunol        ISSN： 0070-217X            Impact factor:   4.291


× No keyword cloud information.
  14 in total

1.  Inhibition of the Complement Alternative Pathway by Chemically Modified DNA Aptamers That Bind with Picomolar Affinity to Factor B.

Authors:  Xin Xu; Chi Zhang; Dalton T Denton; Daniel O'Connell; Daniel W Drolet; Brian V Geisbrecht
Journal:  J Immunol       Date:  2021-01-08       Impact factor: 5.422

Review 2.  Complement component C3 - The "Swiss Army Knife" of innate immunity and host defense.

Authors:  Daniel Ricklin; Edimara S Reis; Dimitrios C Mastellos; Piet Gros; John D Lambris
Journal:  Immunol Rev       Date:  2016-11       Impact factor: 12.988

Review 3.  Advances in understanding the structure, function, and mechanism of the SCIN and Efb families of Staphylococcal immune evasion proteins.

Authors:  Brandon L Garcia; Kasra X Ramyar; Daniel Ricklin; John D Lambris; Brian V Geisbrecht
Journal:  Adv Exp Med Biol       Date:  2012       Impact factor: 2.622

4.  Dynamic structural changes during complement C3 activation analyzed by hydrogen/deuterium exchange mass spectrometry.

Authors:  Michael C Schuster; Daniel Ricklin; Krisztián Papp; Kathleen S Molnar; Stephen J Coales; Yoshitomo Hamuro; Georgia Sfyroera; Hui Chen; Michael S Winters; John D Lambris
Journal:  Mol Immunol       Date:  2008-05-05       Impact factor: 4.407

5.  Mediation of a non-proteolytic activation of complement component C3 by phospholipid vesicles.

Authors:  Yvonne Klapper; Osama A Hamad; Yuji Teramura; Gero Leneweit; G Ulrich Nienhaus; Daniel Ricklin; John D Lambris; Kristina N Ekdahl; Bo Nilsson
Journal:  Biomaterials       Date:  2014-01-23       Impact factor: 12.479

6.  Conformational differences between surface-bound and fluid-phase complement-component-C3 fragments. Epitope mapping by cDNA expression.

Authors:  B Nilsson; D Grossberger; K Nilsson Ekdahl; P Riegert; D J Becherer; U R Nilsson; J D Lambris
Journal:  Biochem J       Date:  1992-03-15       Impact factor: 3.857

7.  Real-time label-free detection of complement activation products in human serum by white light reflectance spectroscopy.

Authors:  Panagiota S Petrou; Daniel Ricklin; Maria Zavali; Ioannis Raptis; Sotirios E Kakabakos; Konstantinos Misiakos; John D Lambris
Journal:  Biosens Bioelectron       Date:  2009-05-03       Impact factor: 10.618

8.  Sites within the complement C3b/C4b receptor important for the specificity of ligand binding.

Authors:  M Krych; D Hourcade; J P Atkinson
Journal:  Proc Natl Acad Sci U S A       Date:  1991-05-15       Impact factor: 11.205

9.  Relationship of Circulating Anti-C3b and Anti-C1q IgG to Lupus Nephritis and Its Flare.

Authors:  Daniel J Birmingham; Joshua E Bitter; Ezinne G Ndukwe; Sarah Dials; Terese R Gullo; Sara Conroy; Haikady N Nagaraja; Brad H Rovin; Lee A Hebert
Journal:  Clin J Am Soc Nephrol       Date:  2015-12-23       Impact factor: 8.237

10.  Inhibitors of C5 complement enhance vaccinia virus oncolysis.

Authors:  D Magge; Z S Guo; M E O'Malley; L Francis; R Ravindranathan; D L Bartlett
Journal:  Cancer Gene Ther       Date:  2013-05-10       Impact factor: 5.987
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.